Humans

A large conditioned pain modulation response is not related to a large blood pressure response: a study in healthy men
BACKGROUND: Endogenous pain modulation has been studied with the conditioned pain modulation (CPM) paradigm with large differences in …
K. B. Nilsen, I. C. Olsen, A. N. Solem, D. Matre
Cite DOI
NOR-DMARD data management: implementation of data capture from electronic health records
OBJECTIVES: The use of electronic health records (EHR) is an essential part of modern health care, and electronic data capture (EDC) …
I. C. Olsen, E. A. Haavardsholm, E. Moholt, T. K. Kvien, E. Lie
Cite
Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity
OBJECTIVE: To assess the predictive value of magnetic resonance imaging (MRI)-detected subclinical inflammation for subsequent …
Frédérique Gandjbakhch, Espen A. Haavardsholm, Philip G. Conaghan, Bo Ejbjerg, Violaine Foltz, Andrew K. Brown, Uffe Møller Døhn, Marissa Lassere, Jane E. Freeston, Inge Christoffer Olsen, Pernille Bøyesen, Paul Bird, Bruno Fautrel, Merete Lund Hetland, Paul Emery, Pierre Bourgeois, Kim Hørslev-Petersen, Tore K. Kvien, Fiona M. McQueen, Mikkel Østergaard
Cite DOI
Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study
BACKGROUND: Physical therapy is recommended for the management of axial spondyloarthritis (axSpA) and flexibility exercises have …
Silje Halvorsen Sveaas, Inger Jorid Berg, Sella Aarrestad Provan, Anne Grete Semb, Kåre Birger Hagen, Nina Vøllestad, Camilla Fongen, Inge C. Olsen, Annika Michelsen, Thor Ueland, Pål Aukrust, Tore K. Kvien, Hanne Dagfinrud
Cite DOI
Carotid plaque characteristics and disease activity in rheumatoid arthritis
OBJECTIVE: Carotid plaques (CP) are predictive of acute coronary syndrome in patients with rheumatoid arthritis (RA), suggesting that …
Anne G. Semb, Silvia Rollefstad, Sella A. Provan, Tore K. Kvien, Einar Stranden, Inge C. Olsen, Jonny Hisdal
Cite DOI
Associations between APOE genotypes and disease susceptibility, joint damage and lipid levels in patients with rheumatoid arthritis
OBJECTIVE: Apolipoprotein E (APOE) genotypes are associated with cardiovascular disease (CVD) and lipid levels. In rheumatoid arthritis …
Marthe T. Maehlen, Sella A. Provan, Diederik P. C. de Rooy, Annette H. M. van der Helm-van Mil, Annemarie Krabben, Tore Saxne, Elisabet Lindqvist, Anne Grete Semb, Till Uhlig, Désirée van der Heijde, Inger Lise Mero, Inge C. Olsen, Tore K. Kvien, Benedicte A. Lie
Cite DOI
A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation
The clinical profile of ibandronate as add-on to calcitriol and calcium was studied in this double-blind, placebo-controlled trial of …
K. T. Smerud, S. Dolgos, I. C. Olsen, A. Åsberg, S. Sagedal, A. V. Reisæter, K. Midtvedt, P. Pfeffer, T. Ueland, K. Godang, J. Bollerslev, A. Hartmann
Cite DOI
Consequences of handling missing data for treatment response in osteoarthritis: a simulation study
OBJECTIVE: To understand how handling of missing data influences the statistical power and bias of treatment effects in randomised …
I. C. Olsen, T. K. Kvien, T. Uhlig
Cite DOI
ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial
OBJECTIVE: To investigate whether ω-3 fatty acids reduce magnetic resonance imaging (MRI) and clinical disease activity in patients …
Oivind Torkildsen, Stig Wergeland, Søren Bakke, Antonie G. Beiske, Kristian S. Bjerve, Harald Hovdal, Rune Midgard, Finn Lilleås, Tom Pedersen, Bård Bjørnarå, Frøydis Dalene, Grethe Kleveland, Jan Schepel, Inge Christoffer Olsen, Kjell-Morten Myhr
Cite DOI
An approach to combining parallel and cross-over trials with and without run-in periods using individual patient data
BACKGROUND: In active run-in trials, where patients may be excluded after a run-in period based on their response to the treatment, it …
Ingunn F. Tvete, Inge C. Olsen, Morten W. Fagerland, Nils Meland, Magne Aldrin, Knut T. Smerud, Lars Holden
Cite DOI